| 1 | Natural Language Processing Identifies Underdocumentation of Symptoms in Patients on Hemodialysis | 1.4 | 5 | Citations (PDF) |
| 2 | kidneyintelX.dkd | 0.2 | 3 | Citations (PDF) |
| 3 | Urinary Biomarkers and Kidney Injury in VA NEPHRON-D: Phenotyping Acute Kidney Injury in Clinical Trials | 1.0 | 5 | Citations (PDF) |
| 4 | Genome-Wide Polygenic Risk Score for CKD in Individuals with APOL1 High-Risk Genotypes | 3.2 | 10 | Citations (PDF) |
| 5 | Comparison of predicting cardiovascular disease hospitalization using individual, ZIP code-derived, and machine learning model-predicted educational attainment in New York City | 1.5 | 2 | Citations (PDF) |
| 6 | Are biomarkers in acute kidney injury ready for prime time? The time is right for a second look | 4.2 | 7 | Citations (PDF) |
| 7 | Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV | 4.2 | 3 | Citations (PDF) |
| 8 | Translational Strategy to Evaluate Urinary Plasminogen as a Targetable Biomarker of Glomerular Diseases | 0.2 | 0 | Citations (PDF) |
| 9 | Longitudinal biomarkers and kidney disease progression after acute kidney injury | 3.7 | 63 | Citations (PDF) |
| 10 | Joint Modeling of Clinical and Biomarker Data in Acute Kidney Injury Defines Unique Subphenotypes with Differing Outcomes | 3.2 | 14 | Citations (PDF) |
| 11 | Do Novel Biomarkers Have Utility in the Diagnosis and Prognosis of AKI? CON | 1.4 | 0 | Citations (PDF) |
| 12 | Associations of Biomarkers of Kidney Tubule Health, Injury, and Inflammation with Left Ventricular Hypertrophy in Children with CKD | 1.4 | 10 | Citations (PDF) |
| 13 | The ASSESS-AKI Study found urinary epidermal growth factor is associated with reduced risk of major adverse kidney events | 4.2 | 28 | Citations (PDF) |
| 14 | SGLT2i and Deterioration of Kidney Function in Heart Failure | 0.7 | 3 | Citations (PDF) |
| 15 | Prognostic Significance of Urinary Biomarkers in Patients Hospitalized With COVID-19 | 1.0 | 51 | Citations (PDF) |
| 16 | Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study | 1.0 | 61 | Citations (PDF) |
| 17 | Kidney Recovery and Death in Critically Ill Patients With COVID-19–Associated Acute Kidney Injury Treated With Dialysis: The STOP-COVID Cohort Study | 1.0 | 42 | Citations (PDF) |
| 18 | Angiopoietins as Prognostic Markers for Future Kidney Disease and Heart Failure Events after Acute Kidney Injury | 0.2 | 33 | Citations (PDF) |
| 19 | Longitudinal TNFR1 and TNFR2 and Kidney Outcomes: Results from AASK and VA NEPHRON-D | 0.2 | 39 | Citations (PDF) |
| 20 | Plasma Biomarkers as Risk Factors for Incident CKD | 2.0 | 23 | Citations (PDF) |
| 21 | A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk | 8.7 | 87 | Citations (PDF) |
| 22 | Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease | 3.2 | 47 | Citations (PDF) |
| 23 | Hemoconcentration of Creatinine Minimally Contributes to Changes in Creatinine during the Treatment of Decompensated Heart Failure | 1.4 | 7 | Citations (PDF) |
| 24 | Effect of Structured, Moderate Exercise on Kidney Function Decline in Sedentary Older Adults | 7.7 | 65 | Citations (PDF) |
| 25 | A Post Hoc Analysis of KidneyIntelX and Cardiorenal Outcomes in Diabetic Kidney Disease | 1.4 | 4 | Citations (PDF) |
| 26 | Optimizing the Design and Analysis of Future AKI Trials | 0.2 | 29 | Citations (PDF) |
| 27 | Systematic Review and Meta-Analysis of Plasma and Urine Biomarkers for CKD Outcomes | 0.2 | 63 | Citations (PDF) |
| 28 | Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure | 8.1 | 8 | Citations (PDF) |
| 29 | Higher Symptom Frequency and Severity After the Long Interdialytic Interval in Patients on Maintenance Intermittent Hemodialysis | 2.0 | 7 | Citations (PDF) |
| 30 | Cost-Effectiveness Analysis of a Prognostic Risk Assessment Test for Diabetic Kidney Disease G1-G3b in the United States | 0.2 | 0 | Citations (PDF) |
| 31 | Urinary Biomarkers and Kidney Injury in the VA NEPHRON-D Trial | 0.2 | 0 | Citations (PDF) |
| 32 | Prognostic Risk Score for Kidney Disease Progression in African Americans Without Type 2 Diabetes | 0.2 | 0 | Citations (PDF) |
| 33 | Cannabis Use and CKD: Epidemiological Associations and Mendelian Randomization | 0.2 | 0 | Citations (PDF) |
| 34 | Biomarker-Enriched Risk Scores and Prognostication of Kidney Outcomes Among African Americans With High-Risk APOL1 Variants | 0.2 | 0 | Citations (PDF) |
| 35 | A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death | 4.2 | 143 | Citations (PDF) |
| 36 | Results from the TRIBE-AKI Study found associations between post-operative blood biomarkers and risk of chronic kidney disease after cardiac surgery | 4.2 | 51 | Citations (PDF) |
| 37 | Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 | 7.7 | 473 | Citations (PDF) |
| 38 | Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States | 1.0 | 197 | Citations (PDF) |
| 39 | AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19 | 0.2 | 265 | Citations (PDF) |
| 40 | Outcomes of Patients on Maintenance Dialysis Hospitalized with COVID-19 | 3.2 | 33 | Citations (PDF) |
| 41 | Bilateral Renal Artery Thrombosis in a Patient With COVID-19 | 2.1 | 19 | Citations (PDF) |
| 42 | Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury | 3.2 | 26 | Citations (PDF) |
| 43 | Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study | 0.2 | 141 | Citations (PDF) |
| 44 | AKI in Hospitalized Patients with COVID-19 | 0.2 | 654 | Citations (PDF) |
| 45 | Payer budget impact of an artificial intelligence in vitro diagnostic to modify diabetic kidney disease progression | 1.5 | 11 | Citations (PDF) |
| 46 | Healthcare utilization and expenditures associated with hyperkalemia management: a retrospective study of Medicare Advantage patients | 1.5 | 7 | Citations (PDF) |
| 47 | Biomarkers of inflammation and repair in kidney disease progression | 6.6 | 174 | Citations (PDF) |
| 48 | Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease | 4.9 | 158 | Citations (PDF) |
| 49 | A qualitative study documenting unmet needs in the management of diabetic kidney disease (DKD) in the primary care setting | 2.1 | 10 | Citations (PDF) |
| 50 | Urinary EGF and MCP-1 and risk of CKD after cardiac surgery | 3.7 | 28 | Citations (PDF) |
| 51 | Predictive Approaches for Acute Dialysis Requirement and Death in COVID-19 | 3.2 | 28 | Citations (PDF) |
| 52 | High Oxalate Concentrations Correlate with Increased Risk for Sudden Cardiac Death in Dialysis Patients | 0.2 | 50 | Citations (PDF) |
| 53 | Achieved blood pressure post-acute kidney injury and risk of adverse outcomes after AKI: A prospective parallel cohort study | 1.5 | 6 | Citations (PDF) |
| 54 | The Association of Posttraumatic Stress Disorder With Longitudinal Change in Glomerular Filtration Rate in World Trade Center Responders | 1.4 | 7 | Citations (PDF) |
| 55 | Hospital-Level Variation in Death for Critically Ill Patients with COVID-19 | 5.0 | 49 | Citations (PDF) |
| 56 | Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID‐19 in the US | 2.8 | 16 | Citations (PDF) |
| 57 | Tribute to Barbara Murphy | 1.4 | 0 | Citations (PDF) |
| 58 | Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial | 4.9 | 82 | Citations (PDF) |
| 59 | Recipient APOL1 risk alleles associate with death-censored renal allograft survival and rejection episodes | 6.6 | 65 | Citations (PDF) |
| 60 | Urine Biomarkers of Kidney Tubule Health, Injury, and Inflammation are Associated with Progression of CKD in Children | 0.2 | 45 | Citations (PDF) |
| 61 | Plasma and urine biomarkers in chronic kidney disease: closer to clinical application | 1.5 | 20 | Citations (PDF) |
| 62 | Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19Chest, 2021, 160, 929-943 | 0.8 | 40 | Citations (PDF) |
| 63 | Provider Recognition of Patient-Reported Symptoms in Patients on Maintenance Hemodialysis | 0.2 | 0 | Citations (PDF) |
| 64 | Prevalence and Association of Dysnatremia with Outcomes in Hospitalized COVID-19 Patients | 0.2 | 0 | Citations (PDF) |
| 65 | Association of Length of Interdialytic Interval and Patient-Reported Symptoms | 0.2 | 0 | Citations (PDF) |
| 66 | Natural language processing of electronic health records is superior to billing codes to identify symptom burden in hemodialysis patients | 4.2 | 49 | Citations (PDF) |
| 67 | Association of plasma-soluble ST2 and galectin-3 with cardiovascular events and mortality following cardiac surgery | 1.8 | 16 | Citations (PDF) |
| 68 | BioPETsurv: Methodology and open source software to evaluate biomarkers for prognostic enrichment of time-to-event clinical trials | 1.5 | 4 | Citations (PDF) |
| 69 | Utilization of Deep Learning for Subphenotype Identification in Sepsis-Associated Acute Kidney Injury | 3.2 | 98 | Citations (PDF) |
| 70 | Acute Kidney Injury in the Time of COVID-19 | 1.4 | 18 | Citations (PDF) |
| 71 | Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US | 7.7 | 814 | Citations (PDF) |
| 72 | Effect of Loop Diuretics on the Fractional Excretion of Urea in Decompensated Heart Failure | 0.9 | 10 | Citations (PDF) |
| 73 | Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease | 2.3 | 15 | Citations (PDF) |
| 74 | The association of standard Kt/V and surface area‐normalized standard Kt/V with clinical outcomes in hemodialysis patients | 0.8 | 7 | Citations (PDF) |
| 75 | Acute Kidney Injury and Risk of CKD and Hypertension after Pediatric Cardiac Surgery | 3.2 | 55 | Citations (PDF) |
| 76 | Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States | 3.4 | 99 | Citations (PDF) |
| 77 | Plasma Biomarkers of Tubular Injury and Inflammation Are Associated with CKD Progression in Children | 0.2 | 66 | Citations (PDF) |
| 78 | Exclusion of Persons with Kidney Disease in Trials of Peripheral Artery Disease | 3.2 | 4 | Citations (PDF) |
| 79 | Derivation and validation of genome-wide polygenic score for urinary tract stone diagnosis | 4.2 | 23 | Citations (PDF) |
| 80 | Systematic Review of the Association Between Worsening Renal Function and Mortality in Patients With Acute Decompensated Heart Failure | 2.0 | 29 | Citations (PDF) |
| 81 | Haptoglobin Phenotype Modifies the Influence of Intensive Glycemic Control on Cardiovascular Outcomes | 0.7 | 43 | Citations (PDF) |
| 82 | Real World Use of Hypertonic Saline in Refractory Acute Decompensated Heart Failure | 2.9 | 104 | Citations (PDF) |
| 83 | Post–Acute Kidney Injury Proteinuria and Subsequent Kidney Disease Progression | 7.7 | 168 | Citations (PDF) |
| 84 | Racial and Ethnic Disparities in Pregnancy-Related Acute Kidney Injury | 1.4 | 14 | Citations (PDF) |
| 85 | Initial Validation of a Machine Learning-Derived Prognostic Test (KidneyIntelX) Integrating Biomarkers and Electronic Health Record Data To Predict Longitudinal Kidney Outcomes | 1.4 | 35 | Citations (PDF) |
| 86 | Bilateral Renal Artery Thrombosis in a COVID-19 Patient with Anuric AKI | 0.2 | 0 | Citations (PDF) |
| 87 | Preoperative Urine Alpha 1 Microglobulin Levels Are Associated with AKI and Mortality After Cardiac Surgery | 0.2 | 0 | Citations (PDF) |
| 88 | Renal Histopathological Post-Mortem Findings of 17 Patients with COVID-19 in New York City | 0.2 | 0 | Citations (PDF) |
| 89 | Machine Learning for Predication of Severe AKI in Hospitalized Patients with COVID-19 | 0.2 | 0 | Citations (PDF) |
| 90 | Trends and Racial Disparities of Palliative Care Use among Hospitalized Patients with ESKD on Dialysis | 0.2 | 58 | Citations (PDF) |
| 91 | The Association of Fenofibrate with Kidney Tubular Injury in a Subgroup of Participants in the ACCORD Trial | 3.2 | 6 | Citations (PDF) |
| 92 | Augmented intelligence with natural language processing applied to electronic health records for identifying patients with non-alcoholic fatty liver disease at risk for disease progression | 2.6 | 58 | Citations (PDF) |
| 93 | Developing Biomarker Panels to Predict Progression of Acute Kidney Injury After Cardiac Surgery | 2.0 | 6 | Citations (PDF) |
| 94 | Association of T Cell–Derived Inflammatory Cytokines With Acute Kidney Injury and Mortality After Cardiac Surgery | 2.0 | 32 | Citations (PDF) |
| 95 | Comparison of Urine and Plasma Biomarker Concentrations Measured by Aptamer-Based versus Immunoassay Methods in Cardiac Surgery Patients | 1.0 | 25 | Citations (PDF) |
| 96 | Are Urinary Biomarkers Better Than Acute Kidney Injury Duration for Predicting Readmission? | 2.6 | 11 | Citations (PDF) |
| 97 | LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-β–Induced Angiogenesis | 0.2 | 147 | Citations (PDF) |
| 98 | The Association of Angiogenesis Markers With Acute Kidney Injury and Mortality After Cardiac Surgery | 1.0 | 48 | Citations (PDF) |
| 99 | Rate of Correction of Hypernatremia and Health Outcomes in Critically Ill Patients | 3.2 | 88 | Citations (PDF) |
| 100 | Synthesizing Markers of Kidney Injury in Acute Decompensated Heart Failure: Should We Even Keep Looking? | 2.0 | 6 | Citations (PDF) |
| 101 | Quantifying Donor Effects on Transplant Outcomes Using Kidney Pairs from Deceased Donors | 3.2 | 10 | Citations (PDF) |
| 102 | Plasma endostatin predicts kidney outcomes in patients with type 2 diabetes | 4.2 | 21 | Citations (PDF) |
| 103 | Effect of Intensive Blood Pressure Lowering on Kidney Tubule Injury: Findings From the ACCORD Trial Study Participants | 1.0 | 66 | Citations (PDF) |
| 104 | Biomarkers of AKI Progression after Pediatric Cardiac Surgery | 0.2 | 75 | Citations (PDF) |
| 105 | The Authors Reply | 0.2 | 0 | Citations (PDF) |
| 106 | Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury | 13.1 | 347 | Citations (PDF) |
| 107 | Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants | 4.2 | 31 | Citations (PDF) |
| 108 | Location-Specific Oral Microbiome Possesses Features Associated With CKD | 2.0 | 42 | Citations (PDF) |
| 109 | Analysis of OPTN/UNOS registry suggests the number of HLA matches and not mismatches is a stronger independent predictor of kidney transplant survival | 4.2 | 38 | Citations (PDF) |
| 110 | Toxic Metals and Chronic Kidney Disease: a Systematic Review of Recent Literature | 4.8 | 91 | Citations (PDF) |
| 111 | Pre‐liver transplant renal dysfunction and association with post‐transplant end‐stage renal disease: A single‐center examination of updated UNOS recommendations | 1.0 | 17 | Citations (PDF) |
| 112 | Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals | 1.2 | 26 | Citations (PDF) |
| 113 | Ptolemy and Copernicus Revisited | 3.2 | 9 | Citations (PDF) |
| 114 | Development of biomarker combinations for postoperative acute kidney injury via Bayesian model selection in a multicenter cohort study | 6.0 | 8 | Citations (PDF) |
| 115 | The prognostic importance of duration of AKI: a systematic review and meta-analysis | 1.5 | 109 | Citations (PDF) |
| 116 | Biomarkers for the detection of renal fibrosis and prediction of renal outcomes: a systematic review | 1.5 | 104 | Citations (PDF) |
| 117 | Plasma Monocyte Chemotactic Protein-1 Is Associated With Acute Kidney Injury and Death After Cardiac Operations | 2.6 | 61 | Citations (PDF) |
| 118 | Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease | 0.2 | 219 | Citations (PDF) |
| 119 | Prophylactic hydration to prevent contrast-induced nephropathy: much ado about nothing? | 4.2 | 6 | Citations (PDF) |
| 120 | Reasons for admission and predictors of national 30-day readmission rates in patients with end-stage renal disease on peritoneal dialysis | 2.5 | 19 | Citations (PDF) |
| 121 | An exploratory analysis of the competing effects of aggressive decongestion and high-dose loop diuretic therapy in the DOSE trial | 1.6 | 31 | Citations (PDF) |
| 122 | National Estimates of 30-Day Unplanned Readmissions of Patients on Maintenance Hemodialysis | 3.2 | 32 | Citations (PDF) |
| 123 | Unplanned 30‐Day Readmissions after Parathyroidectomy in Patients with Chronic Kidney Disease: A Nationwide Analysis | 1.6 | 23 | Citations (PDF) |
| 124 | Performance of Serum Creatinine and Kidney Injury Biomarkers for Diagnosing Histologic Acute Tubular Injury | 1.0 | 106 | Citations (PDF) |
| 125 | Interleukin-8 and Tumor Necrosis Factor Predict Acute Kidney Injury After Pediatric Cardiac Surgery | 2.6 | 56 | Citations (PDF) |
| 126 | Acute Kidney Injury in Patients on SGLT2 Inhibitors: A Propensity-Matched Analysis | 5.6 | 180 | Citations (PDF) |
| 127 | Relationship of Kidney Injury Biomarkers with Long-Term Cardiovascular Outcomes after Cardiac Surgery | 0.2 | 68 | Citations (PDF) |
| 128 | Group analysis identifies differentially elevated biomarkers with distinct outcomes for advanced acute kidney injury in cardiac surgery | 1.0 | 5 | Citations (PDF) |
| 129 | Evaluating biomarkers for prognostic enrichment of clinical trials | 1.3 | 38 | Citations (PDF) |
| 130 | Representation and reporting of kidney disease in cerebrovascular disease: A systematic review of randomized controlled trials | 1.5 | 12 | Citations (PDF) |
| 131 | Urinalysis findings and urinary kidney injury biomarker concentrations | 1.5 | 19 | Citations (PDF) |
| 132 | First Post-Operative Urinary Kidney Injury Biomarkers and Association with the Duration of AKI in the TRIBE-AKI Cohort | 1.5 | 52 | Citations (PDF) |
| 133 | Implementation of Patient-Centered Education for Chronic-Disease Management in Uganda: An Effectiveness Study | 1.5 | 36 | Citations (PDF) |
| 134 | Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial | 0.9 | 186 | Citations (PDF) |
| 135 | Biomarkers for predicting outcomes in chronic kidney disease | 1.5 | 42 | Citations (PDF) |
| 136 | National Trends and Impact of Acute Kidney Injury Requiring Hemodialysis in Hospitalizations With Atrial Fibrillation | 3.1 | 24 | Citations (PDF) |
| 137 | Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial | 3.2 | 104 | Citations (PDF) |
| 138 | Evaluation of Short-Term Changes in Serum Creatinine Level as a Meaningful End Point in Randomized Clinical Trials | 0.2 | 62 | Citations (PDF) |
| 139 | Application of new acute kidney injury biomarkers in human randomized controlled trials | 4.2 | 74 | Citations (PDF) |
| 140 | Dialysis‐requiring acute kidney injury among hospitalized adults with documented hepatitis C Virus infection: a nationwide inpatient sample analysis | 1.3 | 18 | Citations (PDF) |
| 141 | Timing is everything? Reconciling the results of recent trials in acute kidney injury | 4.2 | 1 | Citations (PDF) |
| 142 | Kidney Outcomes 5 Years After Pediatric Cardiac Surgery | 4.6 | 147 | Citations (PDF) |
| 143 | Big data in nephrology: promises and pitfalls | 4.2 | 15 | Citations (PDF) |
| 144 | The Impact of Donor and Recipient Renal Dysfunction on Cardiac Allograft Survival: Insights Into Reno-Cardiac Interactions | 0.9 | 11 | Citations (PDF) |
| 145 | Influence of Titration of Neurohormonal Antagonists and Blood Pressure Reduction on Renal Function and Decongestion in Decompensated Heart Failure | 2.7 | 34 | Citations (PDF) |
| 146 | Representation of Patients With Kidney Disease in Trials of Cardiovascular Interventions | 7.7 | 142 | Citations (PDF) |
| 147 | National trends of acute kidney injury requiring dialysis in decompensated cirrhosis hospitalizations in the United States | 3.5 | 27 | Citations (PDF) |
| 148 | Missed Ischemic Stroke Diagnosis in the Emergency Department by Emergency Medicine and Neurology Services | 4.4 | 205 | Citations (PDF) |
| 149 | Association of Peak Changes in Plasma Cystatin C and Creatinine With Death After Cardiac Operations | 2.6 | 6 | Citations (PDF) |
| 150 | Association of cardiac biomarkers with acute kidney injury after cardiac surgery: A multicenter cohort study | 2.2 | 39 | Citations (PDF) |
| 151 | Temporal Trends in AKI | 3.2 | 11 | Citations (PDF) |
| 152 | Methodological issues in current practice may lead to bias in the development of biomarker combinations for predicting acute kidney injury | 4.2 | 20 | Citations (PDF) |
| 153 | Association of Perioperative Plasma Neutrophil Gelatinase-Associated Lipocalin Levels with 3-Year Mortality after Cardiac Surgery: A Prospective Observational Cohort Study | 1.5 | 19 | Citations (PDF) |
| 154 | Amino-Terminal Pro-B-Type Natriuretic Peptide for Diagnosis and Prognosis in Patients With Renal Dysfunction | 2.9 | 58 | Citations (PDF) |
| 155 | Intravenous Fluids in Acute Decompensated Heart Failure | 2.9 | 37 | Citations (PDF) |
| 156 | Substantial Discrepancy Between Fluid and Weight Loss During Acute Decompensated Heart Failure Treatment | 1.4 | 118 | Citations (PDF) |
| 157 | RiGoR: reporting guidelines to address common sources of bias in risk model development | 6.0 | 27 | Citations (PDF) |
| 158 | Perioperative heart-type fatty acid binding protein is associated with acute kidney injury after cardiac surgery | 4.2 | 32 | Citations (PDF) |
| 159 | Update on Glycemic Control for the Treatment of Diabetic Kidney Disease | 4.1 | 9 | Citations (PDF) |
| 160 | Association of Definition of Acute Kidney Injury by Cystatin C Rise With Biomarkers and Clinical Outcomes in Children Undergoing Cardiac Surgery | 4.6 | 78 | Citations (PDF) |
| 161 | Plasma IL-6 and IL-10 Concentrations Predict AKI and Long-Term Mortality in Adults after Cardiac Surgery | 0.2 | 198 | Citations (PDF) |
| 162 | Urine Biomarkers and Perioperative Acute Kidney Injury: The Impact of Preoperative Estimated GFR | 1.0 | 21 | Citations (PDF) |
| 163 | Creatinine Change on Vasoconstrictors as Mortality Surrogate in Hepatorenal Syndrome: Systematic Review & Meta-Analysis | 1.5 | 15 | Citations (PDF) |
| 164 | Long-term risk of chronic kidney disease and mortality in children after acute kidney injury: a systematic review | 1.5 | 173 | Citations (PDF) |
| 165 | Urinary Biomarkers of AKI and Mortality 3 Years after Cardiac Surgery | 0.2 | 160 | Citations (PDF) |
| 166 | Kidney Function After Off-Pump or On-Pump Coronary Artery Bypass Graft Surgery | 14.4 | 201 | Citations (PDF) |
| 167 | Prevalence and Prognostic Importance of Changes in Renal Function After Mechanical Circulatory Support | 2.7 | 155 | Citations (PDF) |
| 168 | Can We Predict Recovery From Severe Acute Kidney Injury with Biomarkers? | 0.8 | 9 | Citations (PDF) |
| 169 | Developing Risk Prediction Models for Kidney Injury and Assessing Incremental Value for Novel Biomarkers | 3.2 | 30 | Citations (PDF) |
| 170 | Adjudication of etiology of acute kidney injury: experience from the TRIBE-AKI multi-center study | 1.5 | 40 | Citations (PDF) |
| 171 | Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis | 1.5 | 39 | Citations (PDF) |
| 172 | Urinary Biomarkers and Progression of AKI in Patients with Cirrhosis | 3.2 | 98 | Citations (PDF) |
| 173 | Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury | 9.6 | 310 | Citations (PDF) |
| 174 | Blood transfusions are associated with urinary biomarkers of kidney injury in cardiac surgery | 2.2 | 68 | Citations (PDF) |
| 175 | Association Between Preoperative Statin Use and Acute Kidney Injury Biomarkers in Cardiac Surgical Procedures | 2.6 | 44 | Citations (PDF) |
| 176 | Three feasible strategies to minimize kidney injury in 'incipient AKI' | 24.2 | 69 | Citations (PDF) |
| 177 | Blood Urea Nitrogen/Creatinine Ratio Identifies a High-Risk but Potentially Reversible Form of Renal Dysfunction in Patients With Decompensated Heart Failure | 2.7 | 142 | Citations (PDF) |
| 178 | Potential Effects of Digoxin on Long-Term Renal and Clinical Outcomes in Chronic Heart Failure | 0.9 | 25 | Citations (PDF) |
| 179 | Association of AKI With Mortality and Complications in Hospitalized Patients With Cirrhosis | 9.6 | 359 | Citations (PDF) |
| 180 | Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery | 0.7 | 110 | Citations (PDF) |
| 181 | Performance of Kidney Injury Molecule-1 and Liver Fatty Acid-Binding Protein and Combined Biomarkers of AKI after Cardiac Surgery | 3.2 | 213 | Citations (PDF) |
| 182 | Is it AKI or Nonrecovery of Renal Function That Is Important for Long-Term Outcomes? | 3.2 | 24 | Citations (PDF) |
| 183 | Prevention of Chronic Kidney Disease and Subsequent Effect on Mortality: A Systematic Review and Meta-Analysis | 1.5 | 22 | Citations (PDF) |
| 184 | Association of Postoperative Proteinuria with AKI after Cardiac Surgery among Patients at High Risk | 3.2 | 47 | Citations (PDF) |
| 185 | The Association of Albumin/Creatinine Ratio with Postoperative AKI in Children Undergoing Cardiac Surgery | 3.2 | 44 | Citations (PDF) |
| 186 | Preoperative Serum Brain Natriuretic Peptide and Risk of Acute Kidney Injury After Cardiac Surgery | 13.1 | 94 | Citations (PDF) |
| 187 | Traditional Urinary Biomarkers in the Assessment of Hospital-Acquired AKI | 3.2 | 69 | Citations (PDF) |
| 188 | Secular trends in acute dialysis after elective major surgery — 1995 to 2009Cmaj, 2012, 184, 1237-1245 | 0.8 | 119 | Citations (PDF) |
| 189 | Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes Mellitus | 8.1 | 267 | Citations (PDF) |
| 190 | A One-Day Centralized Work-up for Kidney Transplant Recipient Candidates: A Quality Improvement Report | 1.0 | 36 | Citations (PDF) |
| 191 | Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis | 4.2 | 2,068 | Citations (PDF) |
| 192 | Does AKI Truly Lead to CKD? | 0.2 | 174 | Citations (PDF) |
| 193 | Biomarkers Predict Progression of Acute Kidney Injury after Cardiac Surgery | 0.2 | 272 | Citations (PDF) |
| 194 | Determinants of Acute Kidney Injury Duration After Cardiac Surgery: An Externally Validated Tool | 2.6 | 50 | Citations (PDF) |
| 195 | Preoperative proteinuria predicts acute kidney injury in patients undergoing cardiac surgery | 2.2 | 67 | Citations (PDF) |
| 196 | Impact of Changes in Blood Pressure During the Treatment of Acute Decompensated Heart Failure on Renal and Clinical Outcomes | 5.0 | 121 | Citations (PDF) |
| 197 | Presurgical Serum Cystatin C and Risk of Acute Kidney Injury After Cardiac Surgery | 1.0 | 83 | Citations (PDF) |
| 198 | Clinical Characteristics and Outcomes of Patients With Improvement in Renal Function During the Treatment of Decompensated Heart Failure | 0.9 | 91 | Citations (PDF) |
| 199 | Incidence, risk factors, and outcomes of acute kidney injury after pediatric cardiac surgery: A prospective multicenter study* | 0.5 | 470 | Citations (PDF) |
| 200 | Influence of Renal Dysfunction Phenotype on Mortality in the Setting of Cardiac Dysfunction: Analysis of Three Randomized Controlled Trials | 5.0 | 77 | Citations (PDF) |
| 201 | Risk of Poor Outcomes with Novel and Traditional Biomarkers at Clinical AKI Diagnosis | 3.2 | 109 | Citations (PDF) |
| 202 | Prognostic Importance of Early Worsening Renal Function After Initiation of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Cardiac Dysfunction | 2.7 | 233 | Citations (PDF) |
| 203 | Statin Use Associates with a Lower Incidence of Acute Kidney Injury after Major Elective Surgery | 0.2 | 114 | Citations (PDF) |
| 204 | Postoperative Biomarkers Predict Acute Kidney Injury and Poor Outcomes after Adult Cardiac Surgery | 0.2 | 634 | Citations (PDF) |
| 205 | Postoperative Biomarkers Predict Acute Kidney Injury and Poor Outcomes after Pediatric Cardiac Surgery | 0.2 | 360 | Citations (PDF) |
| 206 | The Prognostic Value of Using the Duration of Acute Kidney Injury in Cardiac Surgery: An Example Using Two Antifibrinolytics | 0.8 | 2 | Citations (PDF) |
| 207 | Long-term outcomes of acute kidney injury | 1.5 | 35 | Citations (PDF) |
| 208 | Acute Kidney Injury in Elderly Persons | 1.0 | 213 | Citations (PDF) |
| 209 | Duration of Acute Kidney Injury Impacts Long-Term Survival After Cardiac Surgery | 2.6 | 303 | Citations (PDF) |
| 210 | IL-18 and Urinary NGAL Predict Dialysis and Graft Recovery after Kidney Transplantation | 0.2 | 309 | Citations (PDF) |
| 211 | The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans | 4.2 | 206 | Citations (PDF) |
| 212 | Tubular proteinuria in acute kidney injury: a critical evaluation of current status and future promise | 0.6 | 115 | Citations (PDF) |
| 213 | Urine Microscopy Is Associated with Severity and Worsening of Acute Kidney Injury in Hospitalized Patients | 3.2 | 128 | Citations (PDF) |
| 214 | Searching for Genes That Matter in Acute Kidney Injury | 3.2 | 60 | Citations (PDF) |
| 215 | Long-term Risk of Mortality and Other Adverse Outcomes After Acute Kidney Injury: A Systematic Review and Meta-analysis | 1.0 | 1,074 | Citations (PDF) |
| 216 | Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials | 1.1 | 72 | Citations (PDF) |
| 217 | Recovery of Kidney Function After Acute Kidney Injury in the Elderly: A Systematic Review and Meta-analysis | 1.0 | 311 | Citations (PDF) |
| 218 | Biomarkers for the diagnosis and risk stratification of acute kidney injury: A systematic review | 4.2 | 613 | Citations (PDF) |
| 219 | Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis | 0.7 | 700 | Citations (PDF) |
| 220 | Urinary Biomarkers for Acute Kidney Injury | 3.2 | 159 | Citations (PDF) |
| 221 | Marked variation in the definition and diagnosis of delayed graft function: a systematic review | 0.7 | 354 | Citations (PDF) |
| 222 | The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysisAids, 2008, 22, 1799-1807 | 1.5 | 102 | Citations (PDF) |
| 223 | Long-term Prognosis of Acute Kidney Injury After Acute Myocardial Infarction | 8.1 | 295 | Citations (PDF) |
| 224 | Diagnostic Value of Urine Microscopy for Differential Diagnosis of Acute Kidney Injury in Hospitalized Patients | 3.2 | 174 | Citations (PDF) |
| 225 | Response to ‘Cystatin C: a promising misunderstood biomarker for the diagnosis of acute kidney injury’ | 4.2 | 1 | Citations (PDF) |
| 226 | Prevention of Contrast-induced Nephropathy in High-risk Patients with Hemofiltration | 1.4 | 1 | Citations (PDF) |
| 227 | The Prognostic Importance of a Small Acute Decrement in Kidney Function in Hospitalized Patients: A Systematic Review and Meta-Analysis | 1.0 | 216 | Citations (PDF) |
| 228 | Contribution of Acute Kidney Injury Toward Morbidity and Mortality in Burns: A Contemporary Analysis | 1.0 | 137 | Citations (PDF) |
| 229 | Impact of Chronic Kidney Disease on Health-Related Quality-of-Life Improvement After Coronary Artery Bypass Surgery | 8.1 | 15 | Citations (PDF) |
| 230 | Acute renal failure in hematopoietic cell transplantation | 4.2 | 115 | Citations (PDF) |
| 231 | Long term dietary use of potassium enriched salt reduced cardiovascular death in elderly men | 0.8 | 1 | Citations (PDF) |
| 232 | Underrepresentation of Renal Disease in Randomized Controlled Trials of Cardiovascular Disease | 14.4 | 370 | Citations (PDF) |
| 233 | The Role of Aldosterone Blockers in the Management of Chronic Heart Failure | 0.3 | 6 | Citations (PDF) |
| 234 | Effect of intravenous iron on haemodialysis catheter microbial colonization and blood-borne infection | 1.1 | 24 | Citations (PDF) |
| 235 | The cardiovascular implications of hypokalemia | 1.0 | 46 | Citations (PDF) |
| 236 | Adverse cardiorenal effects of aldosterone: is aldosterone antagonism beneficial? | 1.2 | 1 | Citations (PDF) |
| 237 | Albuminuria and Mortality in Hypertension | 7.3 | 1 | Citations (PDF) |
| 238 | Rapid Communication: Acute Renal Failure Associated with Tenofovir: Evidence of Drug-Induced Nephrotoxicity | 0.3 | 160 | Citations (PDF) |
| 239 | Post Hoc Analyses of DKD Clinical Trials in Ethnic Minorities (Asian, Hispanic, Black) Narrative Review | 1.9 | 2 | Citations (PDF) |
| 240 | Health Outcome Disparities and Determinants of Progression in a Multiethnic Cohort of Patients with IgAN | 0.2 | 0 | Citations (PDF) |
| 241 | Lower Urine Uromodulin Associated with Higher Interstitial Fibrosis and Tubular Atrophy on Kidney Biopsy: A Multicohort Study | 0.2 | 0 | Citations (PDF) |
| 242 | Development of a Point-of-Care Model to Estimate Urine Creatinine Using Urine Dipstick Data | 0.2 | 0 | Citations (PDF) |
